Adrian Signell

Adrian has been with Creator Fund for 2 years where he’s been focused on finding and backing innovative start-ups across the life sciences. Together with fellow CFer Marc Moesser, he has worked closely with Creator Fund portfolio company Baseimmune helping them raise their seed round in late 2021. Adrian is currently finishing up a PhD at King’s College London where he uses genomics to study HIV-1 infection. Previously, he held a governance role at King’s and completed a secondment as a clinical scientist with the NHS where he developed novel testing strategies for COVID-19.